ProQR Therapeutics PRQR
NASDAQ PRQR
$1.63 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014)

Updated

ProQR Therapeutics' Change in Account Payables was $464,552 in the quarter ended Sep 30, 2014, up 293.9% from $117,928 a year earlier.

Analysis

ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 ProQR Therapeutics 171.74 Mn -291.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 464,552.00
Sep 30, 2013 117,928.43
API Access

ProQR Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=PRQR&period=max&api_key=YOUR_API_KEY